Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Obstructive Lung Diseases

  Free Subscription


1 Allergy
1 Am J Respir Cell Mol Biol
1 Am J Respir Crit Care Med
4 Ann Allergy Asthma Immunol
5 Arch Bronconeumol
22 Arch Bronconeumol (Engl Ed)
3 Arerugi
2 Clin Exp Allergy
3 Eur Respir J
3 J Allergy Clin Immunol
2 J Appl Physiol (1985)
2 J Asthma
3 Pediatr Pulmonol
2 PLoS One
4 Respir Med
1 Respir Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. LARSSON SC, Gill D
    Genetic predisposition to allergic diseases is inversely associated with risk of COVID-19.
    Allergy. 2020 Dec 31. doi: 10.1111/all.14728.

    Am J Respir Cell Mol Biol

  2. TRABER KE, Center DM
    Towards a More Precise Solution to Asthma Therapy.
    Am J Respir Cell Mol Biol. 2021 Jun 21. doi: 10.1165/rcmb.2021-0227.

    Am J Respir Crit Care Med

  3. LU Z, Van Eeckhoutte HP, Liu G, Nair PM, et al
    Necroptosis Signalling Promotes Inflammation, Airway Remodelling and Emphysema in COPD.
    Am J Respir Crit Care Med. 2021 Jun 16. doi: 10.1164/rccm.202009-3442.
    PubMed         Abstract available

    Ann Allergy Asthma Immunol

  4. FLOM JD, Chiu YM, Cowell W, Kannan S, et al
    Maternal active asthma in pregnancy influences associations between polyunsaturated fatty acid intake and child asthma.
    Ann Allergy Asthma Immunol. 2021 Jun 19. pii: S1081-1206(21)00450.
    PubMed         Abstract available

  5. CHIABAI J, Friedrich FO, Fernandes MTC, Serpa FS, et al
    Intra-breath oscillometry is a sensitive test for assessing disease control in adults with severe asthma.
    Ann Allergy Asthma Immunol. 2021 Jun 16. pii: S1081-1206(21)00445.
    PubMed         Abstract available

  6. CHAN CRFDR, Lipworth PB
    Impact of Nasal Polyps on Endotype and Phenotype in Moderate to Severe Asthma Patients.
    Ann Allergy Asthma Immunol. 2021 Jun 18. pii: S1081-1206(21)00447.

  7. EID R, Borish L
    Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic.
    Ann Allergy Asthma Immunol. 2021;127:3-4.

    Arch Bronconeumol

  8. BLANCO I, Valeiro B, Torres-Castro R, Barberan-Garcia A, et al
    Effects of Pulmonary Hypertension on Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2019 Nov 23. pii: S0300-2896(19)30407.
    PubMed         Abstract available

  9. MUNOZ-LUCAS MA, Jareno-Esteban J, Gutierrez-Ortega C, Lopez-Guijarro P, et al
    Influence of Chronic Obstructive Pulmonary Disease on Volatile Organic Compounds in Patients with Non-small Cell Lung Cancer.
    Arch Bronconeumol. 2020 Feb 10. pii: S0300-2896(20)30006.
    PubMed         Abstract available

  10. HERRERO MARTIN S, Hueto Perez de Heredia J, Cuesta Remon A, Gomez Fernandez M, et al
    Is a mobile application useful for patients with moderate-severe asthma?
    Arch Bronconeumol. 2021 Jun 16. pii: S1579-2129(21)00188.

  11. TANG J, Ramis-Cabrer D, Curull V, Mateu-Jimenez M, et al
    Markers of Stroma in Lung Cancer: Influence of COPD.
    Arch Bronconeumol. 2020 Sep 24. pii: S0300-2896(20)30311.
    PubMed         Abstract available

  12. DE-TORRES JP, Wisnivesky JP, Bastarrika G, Wilson DO, et al
    Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort.
    Arch Bronconeumol. 2020 May 12. pii: S0300-2896(20)30104.
    PubMed         Abstract available

    Arch Bronconeumol (Engl Ed)

  13. GARCIA-QUERO C, Garcia-Rio F
    Smoking-Induced Small Airway Dysfunction. An Early Marker of Future Copd?
    Arch Bronconeumol (Engl Ed). 2021;57:3-4.

  14. ANCOCHEA J, Soriano JB
    COPD in Spain at the Start of a New Decade.
    Arch Bronconeumol (Engl Ed). 2021;57:1-2.

  15. CRUTHIRDS CL, van der Meij BS, Wierzchowska-McNew A, Deutz NEP, et al
    Presence or Absence of Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease is Associated With Distinct Phenotypes.
    Arch Bronconeumol (Engl Ed). 2021;57:264-272.
    PubMed         Abstract available

  16. IZQUIERDO JL, Morena D, Gonzalez Y, Paredero JM, et al
    Clinical Management of COPD in a Real-World Setting. A Big Data Analysis.
    Arch Bronconeumol (Engl Ed). 2021;57:94-100.
    PubMed         Abstract available

  17. MIRAVITLLES M, Monteagudo M, Solntseva I, Alcazar B, et al
    Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study.
    Arch Bronconeumol (Engl Ed). 2021;57:13-20.
    PubMed         Abstract available

  18. PINA-MAIQUEZ I, Garcia-Lujan R, Revuelta-Salgado F, Margallo-Iribarnegaray J, et al
    Aspergillus Tracheobronchitis. The Diagnostic Value of Endoscopic Imaging.
    Arch Bronconeumol (Engl Ed). 2021;57:226.

  19. KORENY M, Demeyer H, Benet M, Arbillaga-Etxarri A, et al
    Patterns of Physical Activity Progression in Patients With COPD.
    Arch Bronconeumol (Engl Ed). 2021;57:214-223.
    PubMed         Abstract available

  20. LUJAN M, Ergan B
    Guidelines for Chronic Non-invasive Ventilation in COPD: From Experience to Evidence.
    Arch Bronconeumol (Engl Ed). 2021;57:158-159.

  21. GALDIZ JB, Gomez A, Rodriguez D, Guell R, et al
    Telerehabilitation Programme as a Maintenance Strategy for COPD Patients: A 12-Month Randomized Clinical Trial.
    Arch Bronconeumol (Engl Ed). 2021;57:195-204.
    PubMed         Abstract available

  22. HALPIN DMG, Vogelmeier CF, Agusti AA
    COPD & COVID-19.
    Arch Bronconeumol (Engl Ed). 2021;57:162-164.

  23. PLAZA V, Fernandez C, Curto E, Alonso-Ortiz MBN, et al
    Therapeutic Adherence of COPD Patients According to the Involvement Levels in Health Education in their Centers.
    Arch Bronconeumol (Engl Ed). 2021;57:307-309.

  24. MONTEAGUDO M, Nunez A, Solntseva I, Dhalwani N, et al
    Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain.
    Arch Bronconeumol (Engl Ed). 2021;57:205-213.
    PubMed         Abstract available

  25. MIRAVITLLES M, Calle M, Soler-Cataluna JJ
    GesEPOC 2021: One More Step Towards Personalized Treatment of COPD.
    Arch Bronconeumol (Engl Ed). 2021;57:9-10.

  26. SORIANO JB, Alfageme I, Miravitlles M, de Lucas P, et al
    Prevalence and Determinants of COPD in Spain: EPISCAN II.
    Arch Bronconeumol (Engl Ed). 2021;57:61-69.
    PubMed         Abstract available

  27. DIAZ-PENA R, Silva RS, Hosgood HD 3rd, Jaime S, et al
    HLA-DRB1 Alleles are Associated With COPD in a Latin American Admixed Population.
    Arch Bronconeumol (Engl Ed). 2021;57:291-297.
    PubMed         Abstract available

  28. SOLER-CATALUNA JJ, Miralles C
    Exacerbation Syndrome in COPD: A Paradigm Shift.
    Arch Bronconeumol (Engl Ed). 2021;57:246-248.

  29. TANG J, Curull V, Ramis-Cabrer D, Duran X, et al
    Preoperative Body Weight and Albumin Predict Survival in Patients With Resectable Lung Neoplasms: Role of COPD.
    Arch Bronconeumol (Engl Ed). 2021;57:51-60.
    PubMed         Abstract available

  30. CELLI B, Divo M, Plata VP
    Pharmacotherapy Impacts on COPD Mortality.
    Arch Bronconeumol (Engl Ed). 2021;57:5-6.

  31. SORIANO JB, Cosio BG, Lopez-Campos JL, Soler-Cataluna JJ, et al
    Chronic Obstructive Pulmonary Disease and Big Data.
    Arch Bronconeumol (Engl Ed). 2021;57:144.

  32. LOPEZ-CAMPOS JL, Casas-Maldonado F, Torres-Duran M, Medina-Gonzalvez A, et al
    Results of a Diagnostic Procedure Based on Multiplex Technology on Dried Blood Spots and Buccal Swabs for Subjects With Suspected Alpha1 Antitrypsin Deficiency.
    Arch Bronconeumol (Engl Ed). 2021;57:42-50.
    PubMed         Abstract available

  33. MIRAVITLLES M, Sliwinski P, Rhee CK, Costello RW, et al
    Changes in Control Status of COPD Over Time and Their Consequences: A Prospective International Study.
    Arch Bronconeumol (Engl Ed). 2021;57:122-129.
    PubMed         Abstract available

  34. ALCAZAR-NAVARRETE B, Echave-Sustaeta JM
    Microspirometers in the Follow-Up of COPD: Advantages and Disadvantages.
    Arch Bronconeumol (Engl Ed). 2021;57:160-161.


    Arerugi. 2021;70:271-273.

  36. TABATA K, Ueda Y, Okada K, Shimizu T, et al
    Arerugi. 2021;70:310-314.
    PubMed         Abstract available

  37. SASAKI MM, Shimizu K, Suzuki M, Suzuki M, et al
    Arerugi. 2021;70:315-320.
    PubMed         Abstract available

    Clin Exp Allergy

  38. FROSSING L, Silberbrandt A, Von Bulow A, Kjaersgaard Klein D, et al
    Airway gene expression identifies subtypes of Type 2 inflammation in severe asthma.
    Clin Exp Allergy. 2021 Jun 17. doi: 10.1111/cea.13966.
    PubMed         Abstract available

  39. MARGARITTE-JEANNIN P, Budu-Aggrey A, Ege M, Madore AM, et al
    Identification of OCA2 as a novel locus for the co-morbidity of asthma-plus-eczema.
    Clin Exp Allergy. 2021 Jun 22. doi: 10.1111/cea.13972.
    PubMed         Abstract available

    Eur Respir J

  40. DURAND P, Guiddir T, Kyheng C, Blanc F, et al
    A Randomised Trial of High-Flow Nasal Cannula in Infants with Moderate Bronchiolitis.
    Eur Respir J. 2020 May 7. pii: 13993003.01926-2019.
    PubMed         Abstract available

  41. BOUCLY A, Morelot-Panzini C, Garcia G, Weatherald J, et al
    Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension.
    Eur Respir J. 2019 Nov 26. pii: 13993003.02108-2018.
    PubMed         Abstract available

  42. SUISSA S, Dell'Aniello S, Gonzalez AV, Ernst P, et al
    Inhaled corticosteroid use and the incidence of lung cancer in COPD.
    Eur Respir J. 2019 Nov 19. pii: 13993003.01720-2019.
    PubMed         Abstract available

    J Allergy Clin Immunol

  43. LOVINSKY-DESIR S, Lussier SJ, Calatroni A, Gergen PJ, et al
    Trajectories of Adiposity Indicators and Association with Asthma and Lung Function in Urban Minority Children.
    J Allergy Clin Immunol. 2021 Jun 21. pii: S0091-6749(21)00972.
    PubMed         Abstract available

  44. ADIR Y, Humbert M, Saliba W
    COVID-19 risk and outcomes in adult asthmatics treated with biologics or systemic corticosteroids : nationwide real-world evidence.
    J Allergy Clin Immunol. 2021 Jun 15. pii: S0091-6749(21)00938.
    PubMed         Abstract available

  45. GAUTHIER M, Kale SL, Oriss TB, Scholl K, et al
    Dual role for CXCR3 and CCR5 in asthmatic Type 1 inflammation.
    J Allergy Clin Immunol. 2021 Jun 16. pii: S0091-6749(21)00944.
    PubMed         Abstract available

    J Appl Physiol (1985)

  46. TANABE N, Kaji S, Sato S, Yokoyama T, et al
    A homological approach to a mathematical definition of pulmonary fibrosis and emphysema on computed tomography.
    J Appl Physiol (1985). 2021 Jun 17. doi: 10.1152/japplphysiol.00150.2021.
    PubMed         Abstract available

  47. RUTTING S, Chapman DG, Thamrin C, Tang FSM, et al
    The effect of combination inhaled therapy on ventilation distribution measured by SPECT/CT imaging in uncontrolled asthma.
    J Appl Physiol (1985). 2021 Jun 24. doi: 10.1152/japplphysiol.01068.2020.
    PubMed         Abstract available

    J Asthma

  48. TEOH L, Chatfield MD, Acworth JP, McCallum GB, et al
    How Does the Canadian Acute Respiratory Illness and Flu Scale Relate to Other Scales in Pediatric Asthma Exacerbations?
    J Asthma. 2021 Jun 22:1-10. doi: 10.1080/02770903.2021.1946823.
    PubMed         Abstract available

  49. MATHER JF, Mosleh W, McKay RG
    The Impact of Asthma on In-Hospital Outcomes of COVID-19 Patients.
    J Asthma. 2021 Jun 18:1-12. doi: 10.1080/02770903.2021.1944187.
    PubMed         Abstract available


  50. MEHRABADI A, Dodds L, MacDonald NE, Top KA, et al
    Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes.
    JAMA. 2021;325:2285-2293.
    PubMed         Abstract available

    Pediatr Pulmonol

  51. RODRIGUEZ-MARTINEZ CE, Sossa-Briceno MP, Castro-Rodriguez JA
    Cost-utility of omalizumab for the treatment of uncontrolled moderate-to-severe persistent pediatric allergic asthma in a middle-income country.
    Pediatr Pulmonol. 2021 Jun 18. doi: 10.1002/ppul.25541.
    PubMed         Abstract available

  52. KOLETSI P, Antoniadi M, Mermiri D, Koltsida G, et al
    A toddler diagnosed with severe postinfectious bronchiolitis obliterans and COVID-19 infection.
    Pediatr Pulmonol. 2021;56:2381-2384.
    PubMed         Abstract available

  53. FERRERO F, Ossorio MF
    Is there a place for bronchiolitis in the COVID-19 era? Lack of hospitalizations due to common respiratory viruses during the 2020 winter.
    Pediatr Pulmonol. 2021;56:2372-2373.

    PLoS One

  54. VASILEIADOU S, Ekerljung L, Bjerg A, Goksor E, et al
    Asthma increased in young adults from 2008-2016 despite stable allergic rhinitis and reduced smoking.
    PLoS One. 2021;16:e0253322.
    PubMed         Abstract available

  55. ALVES AFF, Miranda JRA, Reis F, Oliveira AA, et al
    Automatic algorithm for quantifying lung involvement in patients with chronic obstructive pulmonary disease, infection with SARS-CoV-2, paracoccidioidomycosis and no lung disease patients.
    PLoS One. 2021;16:e0251783.
    PubMed         Abstract available

    Respir Med

  56. RODRIGUES AT, Romano S, Romao M, Figueira D, et al
    Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial.
    Respir Med. 2021;185:106507.
    PubMed         Abstract available

  57. JEONG JH, Heo M, Kim EJ, Hah YS, et al
    Serum hepatocyte growth factor as a predictor of disease severity and future exacerbations in patients with non-cystic fibrosis bronchiectasis.
    Respir Med. 2021;185:106505.
    PubMed         Abstract available

  58. DUCHENE B, Caffry S, Kaminsky DA, Que LG, et al
    Functional significance of 8-isoprostanes in sinonasal disease and asthma.
    Respir Med. 2021;185:106506.
    PubMed         Abstract available

  59. SHKEIRI R, Saliba W, Stein N, Najjar R, et al
    Exploring factors associated with acquisition and chronicity of infection in bronchiectasis: A population-based study.
    Respir Med. 2021;185:106487.
    PubMed         Abstract available

    Respir Res

  60. LEMIERE C, Taille C, Lee JK, Smith SG, et al
    Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials.
    Respir Res. 2021;22:184.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.